Detalles de la búsqueda
1.
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Br J Haematol
; 204(3): 849-860, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37996986
2.
Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
Ann Surg Oncol
; 31(4): 2425-2438, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253948
3.
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Hematol Oncol
; 42(3): e3272, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38595316
4.
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601.
Ann Hematol
; 103(6): 2021-2031, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280061
5.
A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma.
Jpn J Clin Oncol
; 54(4): 444-451, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271157
6.
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma.
Cancer Sci
; 114(12): 4643-4653, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37921363
7.
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Cancer Sci
; 114(8): 3461-3465, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37232264
8.
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide.
Cancer Immunol Immunother
; 72(8): 2865-2871, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37093243
9.
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Haematologica
; 108(3): 811-821, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36200417
10.
An update on the developments in the treatment of adult T-cell leukemia-lymphoma: current knowledge and future perspective.
Jpn J Clin Oncol
; 53(12): 1104-1111, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592900
11.
Dose-escalation part of Phase I study of single-agent mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
Jpn J Clin Oncol
; 53(10): 912-921, 2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486002
12.
[Diffuse large B-cell lymphoma expressing high-level glyceraldehyde 3-phosphate dehydrogenase complicated with hypoglycemia].
Rinsho Ketsueki
; 64(7): 608-613, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-37544719
13.
Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan.
Jpn J Clin Oncol
; 52(9): 966-974, 2022 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830865
14.
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial.
Jpn J Clin Oncol
; 52(6): 583-588, 2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353186
15.
Safety and antitumor activity of acalabrutinib for relapsed/refractory B-cell malignancies: A Japanese phase I study.
Cancer Sci
; 112(6): 2405-2415, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33728735
16.
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).
Cancer Sci
; 112(12): 5011-5019, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34626515
17.
A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival.
Br J Haematol
; 195(2): 217-229, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34318926
18.
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
Br J Haematol
; 192(3): 531-541, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32583431
19.
Electrostatic-triggered exothermic antibody adsorption to the cellulose nanoparticles.
Anal Biochem
; 632: 114337, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34391727
20.
Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea.
Jpn J Clin Oncol
; 51(2): 218-227, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33051668